What Happened

A Pennsylvania hospital agreed to pay the United States $510,000 to resolve allegations that failures in its controls and practices enabled an employee to divert controlled substances. The hospital found the theft itself and reported it to the DEA in 2013. By the time the audit finished, an inpatient pharmacist had taken more than 35,000 pills, including oxycodone, over at least 85 occasions.

The U.S. Attorney's Office for the Eastern District of Pennsylvania announced the civil settlement on January 9, 2017. The release names the hospital as Abington Memorial Hospital and describes a theft that ran for three and a half years in the hospital's inpatient pharmacy.

“the pharmacist stole more than 35,000 pills, including highly addictive painkillers such as oxycodone”

U.S. Department of Justice / U.S. Attorney's Office press release, Jan 9, 2017

Chronology

Every date below comes from the press release, which gives no month-by-month account of the thefts.

  1. February 1, 2010 to August 20, 2013. On at least 85 occasions in this period, the pharmacist stole more than 35,000 pills from the hospital, including oxycodone.
  2. 2013. The hospital disclosed to the DEA that a pharmacist in its inpatient pharmacy had stolen large volumes of controlled substances. An investigation began after that disclosure.
  3. After the disclosure. The DEA audited the hospital's controlled substances and found pill count discrepancies totaling over 35,000, missing or incomplete medication inventories, and altered or missing drug records.
  4. 2015. In a related federal criminal case, the pharmacist pleaded guilty to 25 counts of possession with intent to distribute oxycodone and was sentenced to six years of imprisonment and three years of supervised release.
  5. January 9, 2017. The hospital's $510,000 civil settlement was announced.

What Failed

The release states the government's position in one sentence: failures in the hospital's controls and practices enabled the employee to divert. It describes them as violations of the hospital's responsibilities under the Controlled Substances Act and federal regulations. The DEA audit findings it lists are:

  • Counts that did not reconcile. Pill count discrepancies totaled more than 35,000.
  • Incomplete inventories. The audit found missing or incomplete medication inventories.
  • Altered or missing records. Drug records were altered or missing.

The release does not list the hospital's original weaknesses one by one. It lists only the measures the hospital added afterward (see Outcome).

How It Was Detected

The hospital detected the theft and told the DEA. The release says the investigation was launched after the hospital disclosed that a pharmacist at its inpatient pharmacy had stolen large volumes of controlled substances. It does not state what first alerted the hospital.

The U.S. Attorney's quoted statement commends the hospital for disclosing its diversion problems. The DEA's audit then found the discrepancies listed under What Failed.

Outcome

The pharmacist was prosecuted and sentenced to six years in prison and three years of supervised release after pleading guilty to 25 counts. The hospital paid $510,000 to resolve the civil allegations and committed to a program to prevent, identify and address future diversion. The release frames the payment as a resolution of allegations, not an adjudicated finding of liability.

The corrective program the release lists falls into four groups:

  • Physical security: an enclosed controlled substances vault, new and additional security cameras, badge-swipe access, a rotary depositary safe, new locked controlled substances and anesthesia carts, and additional intravenous lock boxes.
  • Inventory and ordering: inventory practices that account for bulk and unit dose medications broken down individually, and centralized ordering of controlled substances.
  • Monitoring: daily, biweekly, weekly, monthly and yearly diversion monitoring activities, a Drug Diversion Prevention & Monitoring Committee, and a Task Force for Controlled Substances Infusions-Wasting.
  • Oversight, policy and training: outside consultants to review policies, revised policies with biannual review, more training on storage, serial-number tracking of script pads sent to nursing units, upgrades to inpatient pharmacy computer systems, and a full-time lead supervisor pharmacy technician whose main duty is monitoring the controlled substances workflow from ordering through dispensing.

What a Reader Can Take From It

The release ties three facts together: the thefts ran for more than three years on at least 85 occasions, the hospital reported them itself, and the hospital then added vault, camera, badge-access, ordering, monitoring and supervision controls. The release does not say which of those controls would have shortened the thefts, and it does not say how the government weighed the self-disclosure beyond the quoted commendation.